Cite
HARVARD Citation
Nicum, S. et al. (n.d.). 2761 Phase II clinical trial of 6 mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours. European journal of cancer. pp. S551-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Nicum, S. et al. (n.d.). 2761 Phase II clinical trial of 6 mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours. European journal of cancer. pp. S551-. [Online].